145 related articles for article (PubMed ID: 10338091)
1. Two novel mutations of the FMO3 gene in a proband with trimethylaminuria.
Akerman BR; Forrest S; Chow L; Youil R; Knight M; Treacy EP
Hum Mutat; 1999; 13(5):376-9. PubMed ID: 10338091
[TBL] [Abstract][Full Text] [Related]
2. Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
Yamazaki H; Fujita H; Gunji T; Zhang J; Kamataki T; Cashman JR; Shimizu M
Mol Genet Metab; 2007 Jan; 90(1):58-63. PubMed ID: 16996766
[TBL] [Abstract][Full Text] [Related]
3. Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort.
Akerman BR; Lemass H; Chow LM; Lambert DM; Greenberg C; Bibeau C; Mamer OA; Treacy EP
Mol Genet Metab; 1999 Sep; 68(1):24-31. PubMed ID: 10479479
[TBL] [Abstract][Full Text] [Related]
4. Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.
Ferreira F; Esteves S; Almeida LS; Gaspar A; da Costa CD; Janeiro P; Bandeira A; Martins E; Teles EL; Garcia P; Azevedo L; Vilarinho L
Gene; 2013 Sep; 527(1):366-70. PubMed ID: 23791655
[TBL] [Abstract][Full Text] [Related]
5. Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
Shimizu M; Kobayashi Y; Hayashi S; Aoki Y; Yamazaki H
Mol Genet Metab; 2012 Nov; 107(3):330-4. PubMed ID: 22819296
[TBL] [Abstract][Full Text] [Related]
6. Population-specific polymorphisms of the human FMO3 gene: significance for detoxication.
Cashman JR; Akerman BR; Forrest SM; Treacy EP
Drug Metab Dispos; 2000 Feb; 28(2):169-73. PubMed ID: 10640514
[TBL] [Abstract][Full Text] [Related]
7. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.
Zhou J; Shephard EA
Mutat Res; 2006 Jun; 612(3):165-171. PubMed ID: 16481213
[TBL] [Abstract][Full Text] [Related]
8. Trimethylaminuria and a human FMO3 mutation database.
Hernandez D; Addou S; Lee D; Orengo C; Shephard EA; Phillips IR
Hum Mutat; 2003 Sep; 22(3):209-13. PubMed ID: 12938085
[TBL] [Abstract][Full Text] [Related]
9. Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria.
Zhang J; Tran Q; Lattard V; Cashman JR
Pharmacogenetics; 2003 Aug; 13(8):495-500. PubMed ID: 12893987
[TBL] [Abstract][Full Text] [Related]
10. Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.
Cashman JR; Bi YA; Lin J; Youil R; Knight M; Forrest S; Treacy E
Chem Res Toxicol; 1997 Aug; 10(8):837-41. PubMed ID: 9282831
[TBL] [Abstract][Full Text] [Related]
11. In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene.
Lambert DM; Mamer OA; Akerman BR; Choinière L; Gaudet D; Hamet P; Treacy EP
Mol Genet Metab; 2001 Jul; 73(3):224-9. PubMed ID: 11461189
[TBL] [Abstract][Full Text] [Related]
12. Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3).
Allerston CK; Shimizu M; Fujieda M; Shephard EA; Yamazaki H; Phillips IR
Pharmacogenet Genomics; 2007 Oct; 17(10):827-39. PubMed ID: 17885620
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.
Yeung CK; Adman ET; Rettie AE
Arch Biochem Biophys; 2007 Aug; 464(2):251-9. PubMed ID: 17531949
[TBL] [Abstract][Full Text] [Related]
14. FMO3 allelic variants in Sicilian and Sardinian populations: trimethylaminuria and absence of fish-like body odor.
D'Angelo R; Esposito T; Calabrò M; Rinaldi C; Robledo R; Varriale B; Sidoti A
Gene; 2013 Feb; 515(2):410-5. PubMed ID: 23266626
[TBL] [Abstract][Full Text] [Related]
15. A spectrum of molecular variation in a cohort of Italian families with trimethylaminuria: identification of three novel mutations of the FM03 gene.
Teresa E; Lonardo F; Fiumara A; Lombardi C; Russo P; Zuppi C; Scarano G; Musumeci S; Gianfrancesco F
Mol Genet Metab; 2006 Jun; 88(2):192-5. PubMed ID: 16600650
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication.
Treacy EP; Akerman BR; Chow LM; Youil R; Bibeau C; Lin J; Bruce AG; Knight M; Danks DM; Cashman JR; Forrest SM
Hum Mol Genet; 1998 May; 7(5):839-45. PubMed ID: 9536088
[TBL] [Abstract][Full Text] [Related]
17. Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.
Motika MS; Zhang J; Zheng X; Riedler K; Cashman JR
Mol Genet Metab; 2009 Jun; 97(2):128-35. PubMed ID: 19321370
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FM03) gene in patients with fish-odour syndrome.
Dolphin CT; Janmohamed A; Smith RL; Shephard EA; Phillips IR
Pharmacogenetics; 2000 Dec; 10(9):799-807. PubMed ID: 11191884
[TBL] [Abstract][Full Text] [Related]
19. A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria.
Forrest SM; Knight M; Akerman BR; Cashman JR; Treacy EP
Pharmacogenetics; 2001 Mar; 11(2):169-74. PubMed ID: 11266081
[TBL] [Abstract][Full Text] [Related]
20. Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism.
Cashman JR
Pharmacogenomics; 2002 May; 3(3):325-39. PubMed ID: 12052141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
